opioid crisis

Regulatory Control of Potentially Addictive Drugs

Regulatory Control of Potentially Addictive Drugs

Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.

Federal Agencies Should Extend Pandemic Flexibilities for Opioid Use Disorder

Federal Agencies Should Extend Pandemic Flexibilities for Opioid Use Disorder

A new report offers recommendations for extending telehealth treatment of opioid use disorder.

The Mess of Meth Lab Cleanups

The Mess of Meth Lab Cleanups

Regulations on decontaminating former meth labs vary across federal and state governments.

Combatting Covert Chemistry Operations

Combatting Covert Chemistry Operations

To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.

An Epidemic Meets a Pandemic

An Epidemic Meets a Pandemic

Amid the coronavirus, the federal government eases restrictions on prescribing controlled substances by telehealth.

Relaxing Patient Privacy Laws to Tackle Substance Abuse

Relaxing Patient Privacy Laws to Tackle Substance Abuse

To fight opioid misuse, the U.S. government proposes expanding access to medical records on substance use.

Regulation and the Opioid Epidemic

Regulation and the Opioid Epidemic

This Saturday Seminar explores how regulation addresses and affects opioid use and addiction.

The Regulatory Battle Over Safe Injection Sites

The Regulatory Battle Over Safe Injection Sites

As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.